LEXINGTON, Mass.--(BUSINESS WIRE)--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced it will report unaudited consolidated financial results for the third quarter ended September 30, 2009 before the U.S. financial markets open on October 29, 2009. The announcement will be followed by a conference call at 8:30 a.m. ET during which management will discuss the Company’s third quarter financial results, development programs, and the recent launch of Feraheme™ (ferumoxytol) Injection.
